WCLC 2026 Wrap – Summit’s Dilemma; GSK, Merck, Amgen Vie in SCLC: BI Replay

On Demand

Duration: 48 Minutes

Original Date: September 22, 2026

First name

Last name

Business email

Business phone

Company

Job role

Industry

City

Country or Region

State or Province Optional

Yes, I would like to be contacted by a representative to learn more about Bloomberg's solutions and services.

What are you interested in learning more about?

By submitting this information, I agree to the privacy policy and to learn more about products and services from Bloomberg.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Join Bloomberg Intelligence analysts Sam Fazeli and Javier Manso as they discuss key takeaways from WCLC in Seoul, including Akeso’s HARMONi-2 survival update, the outlook for PD-(L)1xVEGF bispecifics as immunotherapy backbones, rising B7-H3 ADC competition in small-cell lung cancer and key company read-throughs.

WCLC 2026 Wrap – Summit’s Dilemma; GSK, Merck, Amgen Vie in SCLC: BI Replay

Access a broad range of analysis, research, insight and actionable ideas with Bloomberg webinars.